secwatch / observer

Material Agreements

Entry into or termination of material definitive agreements (Items 1.01/1.02).

8-K items 1.01, 1.02 JSON
TROX Tronox Holdings plc

Tronox Holdings plc entered into Amendment No. 4 with HSBC Bank USA, National Association valued at $741,000,000 (effective 2024-05-01).

“On May 1, 2024, Tronox Finance LLC (the “Borrower”), an indirect subsidiary of Tronox Holdings plc (the “Company”), together with the Company and certain of the Company’s subsidiaries, entered into Amendment No. 4 (the “Amendment”) to the Credit Agreement (as defined below) with the term lenders party thereto and HSBC Bank USA, National Association, as Administrative Agent and Collateral Agent. The Amendment provides the Borrower with a new five-year incremental term loan facility (the “2024 Other Term Facility” and the loans thereunder, the “2024 Other Term Loans”) in an aggregate principal amount of $741,000,000”
XTIA XTI Aerospace, Inc.

XTI Aerospace, Inc. entered into Purchase Agreement with Streeterville Capital, LLC valued at $1,305,000.00 (effective 2024-05-01).

“On May 1, 2024, XTI Aerospace, Inc. (the “Company”) entered into a note purchase agreement (the “Purchase Agreement”) with Streeterville Capital, LLC (the “Holder”), pursuant to which the Company agreed to issue and sell to the Holder a secured promissory note (the “Note”) in an initial principal amount of $1,305,000.00 (the “Initial Principal Amount”)”
PETV PetVivo Holdings, Inc.

PetVivo Holdings, Inc. entered into Conversion Agreement with A.L. Sarroff Fund, LLC valued at total principal amount of $300,000, plus accrued interest of $1,558 (effective 2024-04-29).

“Effective as of April 29, 2024, A.L. Sarroff Fund, LLC (the “Lender”), a greater than 10% shareholder in PetVivo Holdings, Inc. (the “Company”) entered into a note conversion agreement dated April 29, 2024 (“Conversion Agreement”) to convert the outstanding balance of a promissory note (“Note”) dated April 10, 2024, in the total principal amount of $300,000, plus accrued interest of $1,558 into 430,798 Units”
DecisionPoint Systems, Inc.

DecisionPoint Systems, Inc. entered into Agreement and Plan of Merger with Barcoding Derby Buyer, Inc.; Derby Merger Sub, Inc. (effective 2024-04-30).

“On April 30, 2024, DecisionPoint Systems, Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with Barcoding Derby Buyer, Inc., a Delaware corporation (“Parent”), and Derby Merger Sub, Inc., a Delaware corporation and wholly owned subsidiary of Parent (“MergerCo”).”
NUWE Nuwellis, Inc.

Nuwellis, Inc. entered into Warrant Agency Agreement with Equiniti Trust Company, LLC (effective 2024-04-30).

“On April 30, 2024, the Company also entered into a Warrant Agency Agreement with the Company’s transfer agent, Equiniti Trust Company, LLC, who will act as warrant agent for the Company, setting forth the terms and conditions of the Common Warrants sold in this Offering (the “ Warrant Agency Agreement ”).”
NUWE Nuwellis, Inc.

Nuwellis, Inc. entered into Securities Purchase Agreement with certain of the purchasers in the Offering (effective 2024-04-26).

“On April 26, 2024, the Company entered into a Securities Purchase Agreement (the “ Purchase Agreement ”) with certain of the purchasers in the Offering.”
NUWE Nuwellis, Inc.

Nuwellis, Inc. entered into Placement Agency Agreement with Roth Capital Partners, LLC (effective 2024-04-26).

“On April 26, 2024, Nuwellis, Inc. (the “ Company ”) entered into a Placement Agency Agreement (the “ Placement Agency Agreement ”) with Roth Capital Partners, LLC (the “ Placement Agent ”), pursuant to which the Company issued and sold, in a best efforts registered public offering by the Company (the “ Offering ”), 8,419,996 shares (the “ Shares ”) of the Company’s common stock, par value $0.0001 per share (the “ Common Stock ”) , pre-funded warrants (the “ Pre-Funded Warrants ”) to purchase up to an aggregate of 2,830,004 shares of common stock and common warrants (the “ Common Warrants ) to purchase up to an aggregate of 16,875,000 shares of its common stock.”
Territorial Bancorp Inc.

Territorial Bancorp Inc. entered into Voting Agreement with directors and certain executive officers of Territorial Bancorp (effective 2024-04-26).

“On April 26, 2024, in connection with the execution of the Merger Agreement, Hope Bancorp entered into a voting agreement (the “Voting Agreement”) with the directors and certain executive officers of Territorial Bancorp.”
Territorial Bancorp Inc.

Territorial Bancorp Inc. entered into Agreement and Plan of Merger with Hope Bancorp, Inc. (effective 2024-04-26).

“On April 26, 2024, Hope Bancorp, Inc., a Delaware corporation (“Hope Bancorp”), and Territorial Bancorp Inc., a Maryland corporation (“Territorial Bancorp”), entered into an Agreement and Plan of Merger (the “Merger Agreement”).”
CLW Clearwater Paper Corp

Clearwater Paper Corp amended Non-ABL Credit Agreement with AgWest Farm Credit, PCA, as administrative agent, and the lenders party thereto valued at $400 million.

“On the Closing Date (as defined below), Clearwater Paper Corporation (the “Company”) entered into an amendment and restatement of its credit agreement, dated October 27, 2023 by and among the Company, AgWest Farm Credit, PCA, as administrative agent (the “Agent”), and the lenders party thereto (as amended, the “Non-ABL Credit Agreement”).”
CETX CEMTREX INC

CEMTREX INC entered into Standstill Agreement with Streeterville Capital, LLC valued at the greater of $4 million or fifty percent (50%) of the net proceeds (effective 2024-04-30).

“On April 30, 2024, Cemtrex, Inc., a Delaware corporation (the “Company”) entered into a Standstill Agreement (the “Agreement”) with Streeterville Capital, LLC (“Streeterville”).”
RNTX Rein Therapeutics, Inc.

Rein Therapeutics, Inc. entered into Underwriting Agreement with Titan Partners Group LLC, a division of American Capital Partners, LLC valued at combined offering price of $4.68 (effective 2024-05-01).

“On May 1, 2024, Aileron Therapeutics, Inc. (the “Company”) entered into an underwriting agreement (the “Underwriting Agreement”) with Titan Partners Group LLC, a division of American Capital Partners, LLC, as underwriter (the “Underwriter”), relating to an underwritten offering (the “Offering”) of 4,273,505 shares (the “Shares”) of the Company’s common stock, par value $0.001 per share (the “Common Stock”) and accompanying warrants (“Warrants”) to purchase 4,273,505 shares of Common Stock.”
WTI W&T OFFSHORE INC

W&T OFFSHORE INC amended Seventeenth Amendment to the Sixth Amended and Restated Credit Agreement with Alter Domus (US) LLC as administrative agent and certain lenders valued at extend the maturity date from April 30, 2024 to May 31, 2024 (effective 2024-04-29).

“On April 29, 2024, W&T Offshore, Inc. (together with its guarantor subsidiaries, the “Company”) entered into a Seventeenth Amendment to the Sixth Amended and Restated Credit Agreement (the “Seventeenth Amendment”) dated as of April 29, 2024, among the Company, certain of its guarantor subsidiaries, Alter Domus (US) LLC, as administrative agent, and certain of the Company’s lenders and other parties thereto (as heretofore amended, the “Credit Agreement”).”
APLD Applied Digital Corp.

Applied Digital Corp. entered into Cooperation and Standstill Agreement with Oasis Management Co., Ltd. valued at Entry into Cooperation and Standstill Agreement with Oasis appointing Ella Benson to the Board and a (effective 2024-04-30).

“On April 30, 2024, Applied Digital Corporation (the “Company”) entered into a Cooperation and Standstill Agreement (the “Agreement”) with Oasis Management Co., Ltd. (“Oasis”), pursuant to which Oasis agreed to certain cooperation and standstill provisions and the Company agreed to appoint Ella Benson, an employee of Oasis, to the Company’s Board of Directors (the “Board”) as an independent director and as Chairperson of the Board’s Nominating and Governance Committee and further agreed to nominate Ms. Benson for election as a director of the Company at the Company’s 2024 and 2025 annual meetings of stockholders and to continue her tenure as Chair of the Nominating and Governance Committee in accordance with the terms and conditions set forth in the Agreement.”
PRPO Precipio, Inc.

Precipio, Inc. terminated Factoring Agreement with Culain Capital Funding, LLC (effective 2024-04-30).

“On April 30, 2024, Precipio Inc. (“Precipio”) terminated the Factoring Agreement with Culain Capital Funding, LLC, dated March 23, 2023 (the “Factoring Agreement”).”
TRIUMPH GROUP INC

TRIUMPH GROUP INC amended Cooperation Agreement Amendment with Vision One Management Partners, LP valued at Pursuant to the terms of the Amendment, the slate of director nominees recommended by the Board for (effective 2024-05-01).

“(the “ Company ”) entered into a cooperation agreement (the “ Agreement ”) with Vision One Management Partners, LP (“ Vision One ”). On May 1, 2024, the Company and Vision One entered into an amendment to the Agreement (the “ Amendment ”).”
UNFI UNITED NATURAL FOODS INC

UNITED NATURAL FOODS INC amended Amendment No. 1 to the ABL Loan Agreement with Wells Fargo Bank, National Association valued at $130 million (effective 2024-05-01).

“On May 1, 2024, the Company entered into Amendment No. 1 (the “ABL Amendment”) to the loan agreement dated June 3, 2022, by and among the Company, UNFI Canada, Inc., the financial institutions that are parties thereto as lenders, Wells Fargo Bank, National Association and the other parties thereto (the “ABL Loan Agreement”) to execute on a First In, Last Out (“FILO”) tranche of incremental loans under the ABL Loan Agreement.”
UNFI UNITED NATURAL FOODS INC

UNITED NATURAL FOODS INC amended Amendment No. 4 to the Term Loan Agreement with JPMorgan Chase Bank, N.A., as administrative agent and collateral agent valued at $500 million (effective 2024-05-01).

“On May 1, 2024, United Natural Foods, Inc. (the “Company”), SUPERVALU INC., UNFI Wholesale, Inc., and UNFI Distribution Company, LLC (the “Co-Borrowers” and, together with the Company, the “Borrowers”), the guarantors party thereto, the certain financial institutions that are parties thereto as lenders, and JPMorgan Chase Bank, N.A., as administrative agent and collateral agent (the “Agent”), entered into Amendment No. 4 to the Term Loan Agreement (the “Term Loan Amendment”), amending the Term Loan Agreement dated as of October 22, 2018, as amended from time to time (as further amended, the “Term Loan Agreement”), among the Borrowers, the guarantors party thereto, the lenders from time to time party thereto and the Agent.”
GPUS Hyperscale Data, Inc.

Hyperscale Data, Inc. entered into Note with an accredited investor valued at $1,705,000 (effective 2024-04-29).

“Effective April 29, 2024, Ault Alliance, Inc., a Delaware corporation (the “ Company ”) issued to an accredited investor a term note (the “ Note ”) with a principal face amount of $1,705,000.”
CAG CONAGRA BRANDS INC.

CONAGRA BRANDS INC. entered into Term Loan Agreement with Bank of America, N.A., as administrative agent and a lender, and the other lenders party thereto valued at $300.0 million (effective 2024-04-29).

“On April 29, 2024, Conagra Brands, Inc. (the “Company”) entered into a Term Loan Agreement (the “Term Loan Agreement”) with Bank of America, N.A. (“Bank of America”), as administrative agent and a lender, and the other lenders (if any) party thereto, providing for term loans to the Company in an aggregate principal amount of $300.0 million.”
ECD Automotive Design, Inc.

ECD Automotive Design, Inc. entered into A&R Asset Purchase Agreement with BNMC Continuation Cars LLC and David W. Miller II valued at up to $1.25 million (effective 2024-04-24).

“On April 24, 2024, the Company entered into an Amended and Restated Asset Purchase Agreement (the A&R Asset Purchase Agreement") with Sellers, pursuant to which the Company agreed to purchase certain assets relating to vehicle builds, including the trademark "Brand New Muscle Car" (the "Purchased Assets") from Sellers in exchange for up to $1.25 million.”
Hempacco Co., Inc.

Hempacco Co., Inc. entered into SPA with Mast Hill Fund, L.P. valued at $379,288.88 (effective 2024-04-24).

“Effective April 24, 2024, Hempacco Co., Inc. (the “ Company ”), entered into a securities purchase agreement (the “ SPA ”) with Mast Hill Fund, L.P., a Delaware limited partnership (“ Mast Hill ”), pursuant to which the Company sold, and Mast Hill purchased, (i) a convertible promissory note in the principal amount of $379,288.88 (the “ Note ”), and (ii) warrants to purchase 113,786 shares of Company common stock (the “ Warrants ”), for an aggregate purchase price of $341,360”
Real Good Food Company, Inc.

Real Good Food Company, Inc. amended Amendment to Amended and Restated Loan and Security Agreement with PMC Financial Services Group, LLC valued at Revised revolving credit facility maturity date extended to December 31, 2026; $90.0 million term lo (effective 2024-04-26).

“On April 26, 2024, Real Good Foods, LLC, a wholly owned subsidiary of The Real Good Food Company, Inc. (the “Company”), entered into an amendment (the “Amendment”) to its amended and restated Loan and Security Agreement with PMC Financial Services Group, LLC (“PMC”), dated June 30, 2016 (the “Existing Credit Facility”).”
CYCU Cycurion, Inc.

Cycurion, Inc. amended Amended and Restated Business Combination Agreement with Western Acquisition Ventures Corp. and Western Acquisition Merger Inc. valued at Amendment to the Business Combination Agreement to amend economic terms at closing and extend termin (effective 2024-04-26).

“On April 26, 2024, the Parties amended and restated the Business Combination Agreement (the “ Amended and Restated Business Combination Agreement ”) to amend, among other things, certain economic terms at the closing of the Business Combination and the Termination Date to complete the Business Combination, defined in the Section 1.1 of the Business Combination Agreement, from December 31, 2023 to December 31, 2024.”
Aquaron Acquisition Corp.

Aquaron Acquisition Corp. amended Trust Amendment with Continental Stock Transfer & Trust Company (effective 2023-04-30).

“As approved by its stockholders at the annual meeting of Stockholders held on April 30, 2024 (the “ Annual Meeting ”), Aquaron Acquisition Corp. (“ Aquaron ” or the “ Company ”) entered into an amendment to the Investment Management Trust Agreement, dated as of October 3, 2022 and as amended on June 29, 2023, with Continental Stock Transfer & Trust Company, on April 30, 2023 (the “ Trust Amendment ”).”
Akili, Inc.

Akili, Inc. amended Shionogi Amendment with Shionogi & Co., Ltd. valued at $10.5 million within 30 business days of the Amendment Effective Date (effective 2024-04-26).

“On April 26, 2024, the Company and Shionogi entered into a further amendment (the “Shionogi Amendment”, and such date the “Amendment Effective Date”) to the Shionogi Agreement”
JBI Janus International Group, Inc.

Janus International Group, Inc. amended Repricing Amendment with UBS AG, Stamford Branch; Goldman Sachs Bank USA (effective 2024-04-30).

“On April 30, 2024, Janus International Group, Inc. (the “Company”) completed a repricing pursuant to Amendment No. 7 (the “Repricing Amendment”) to that certain First Lien Credit and Guarantee Agreement (the “First Lien”), dated as of February 12, 2018, by and among Janus Intermediate, LLC, a wholly owned subsidiary of the Company (“Janus Intermediate”), Janus International Group, LLC, a wholly owned subsidiary of the Company (“Janus International”), UBS AG, Stamford Branch, as administrative agent and collateral agent, Goldman Sachs Bank USA, as successor administrative agent and collateral agent and the other parties thereto.”
TLSI TriSalus Life Sciences, Inc.

TriSalus Life Sciences, Inc. entered into Credit Agreement with OrbiMed Royalty & Credit Opportunities IV, LP valued at Up to $50 million senior secured credit facility, $25 million initial borrowing on April 30, 2024, $ (effective 2024-04-30).

“On April 30, 2024 (the “ Closing Date ”), TriSalus Life Sciences, Inc., a Delaware corporation (the “ Company ”) and TriSalus Operating Life Sciences, Inc., a Delaware corporation and wholly owned subsidiary of the Company (the “ Borrower ”) entered into a Credit Agreement (the “ Credit Agreement ”), by and between the Company, as parent, the Borrower, as borrower, OrbiMed Royalty & Credit Opportunities IV, LP, a Delaware limited partnership (the “ Initial Lender ”), as a lender, and each other lender that may from time to time become a party thereto (each, including the Initial Lender, and together with their affiliates, successors, transferees and assignees, the “ Lenders ”), and OrbiMed Royalty & Credit Opportunities IV, LP, as administrative agent for the Lenders (in such capacity, the “ Administrative Agent ”).”
Acreage Holdings, Inc.

Acreage Holdings, Inc. amended seventh amendment to the Floating Share Arrangement Agreement with Canopy Growth Corporation and Canopy USA, LLC (effective 2024-04-25).

“On April 25, 2024, Acreage, Canopy and Canopy USA entered into a seventh amendment to the Floating Share Arrangement Agreement (the “Amendment”).”
FSUN FIRSTSUN CAPITAL BANCORP

FIRSTSUN CAPITAL BANCORP amended First Amendment to Acquisition Finance Securities Purchase Agreement with Wellington Management and certain other institutional accredited investors valued at Additional investment of $45 million for an aggregate total investment of $140 million; sale and iss (effective 2024-04-30).

“Concurrently with its entry into the Amendment, on April 30, 2024, FirstSun entered into a First Amendment to Acquisition Finance Securities Purchase Agreement (the “ AFSPA Amendment ”) dated January 16, 2024, with certain funds managed by Wellington Management (“ Wellington ”) and certain other institutional accredited investors (each, an “ Additional Investor ” and, collectively with Wellington, the “ Investors ”).”
FSUN FIRSTSUN CAPITAL BANCORP

FIRSTSUN CAPITAL BANCORP amended Amendment No. 1 to Agreement and Plan of Merger with HomeStreet, Inc., Dynamis Subsidiary, Inc. valued at Increase in FirstSun's total equity capital raise from $175 million to up to $235 million; reduced E (effective 2024-04-30).

“On April 30, 2024, FirstSun Capital Bancorp, a Delaware corporation (“ FirstSun ”), entered into Amendment No. 1 (the “ Amendment ”) to the Agreement and Plan of Merger, dated January 16, 2024 (the “ Merger Agreement ”), by and among HomeStreet, Inc., a Washington corporation (“ HomeStreet ”), FirstSun, and Dynamis Subsidiary, Inc., a Washington corporation and wholly owned subsidiary of FirstSun (“ Merger Sub ”).”
SMPL Simply Good Foods Co

Simply Good Foods Co entered into Purchase Agreement with Safe Brands, LLC valued at $280,000,000 (effective 2024-04-29).

“On April 29, 2024, Simply Good Foods USA, Inc., a New York corporation (“ Simply USA ”), entered into a Stock Purchase Agreement (the “ Purchase Agreement ”) with Safe Brands, LLC, a Delaware limited liability company (“ Seller ”), and Only What You Need, Inc., a Delaware corporation (“ Target ”).”
DVLT Datavault AI Inc.

Datavault AI Inc. entered into the Placement Agency Agreement with Maxim Group LLC (the “Placement Agent”) valued at 8.0% of the gross proceeds raised in the Offerings (effective 2024-04-26).

“on April 26, 2024, the Company entered into a placement agency agreement (the “Placement Agency Agreement”) with Maxim Group LLC (the “Placement Agent”), pursuant to which the Placement Agent agreed to act as placement agent on a “reasonable best efforts” basis in connection with the Offerings.”
DVLT Datavault AI Inc.

Datavault AI Inc. entered into the Purchase Agreement with certain purchasers signatory to that certain securities purchase agreement dated April 26, 2024 valued at aggregate gross proceeds of approximately $2.4 million (effective 2024-04-30).

“On April 30, 2024, WiSA Technologies, Inc. (the “Company”), closed (the “Closing”) an offering with certain purchasers signatory to that certain securities purchase agreement dated April 26, 2024 (the “Purchase Agreement”).”
ALZN Alzamend Neuro, Inc.

Alzamend Neuro, Inc. entered into the Guaranty with Ault Lending (effective 2024-04-29).

“Ault Lending Additional Closing On April 29, 2024, Alzamend Neuro, Inc., a Delaware corporation (the “ Company ”), pursuant to the Securities Purchase Agreement (the “ Agreement ”)”
ALZN Alzamend Neuro, Inc.

Alzamend Neuro, Inc. entered into the Note with an accredited investor valued at $310,000 (effective 2024-04-29).

“Effective April 29, 2024, the Company issued to an accredited investor a term note (the “ Note ”) with a principal face amount of $310,000”
ALZN Alzamend Neuro, Inc.

Alzamend Neuro, Inc. entered into the Securities Purchase Agreement with Ault Lending, LLC valued at $2.1 million (effective 2024-01-31).

“lzamend Neuro, Inc., a Delaware corporation (the “ Company ”), pursuant to the Securities Purchase Agreement (the “ Agreement ”) entered into with Ault Lending, LLC, a California limited liability company (“ Ault Lending ”) on January 31, 2024, sold”
NYC American Strategic Investment Co.

American Strategic Investment Co. amended Amendment with Capital One, National Association (effective 2024-04-29).

“On April 29, 2024, ARC NYC 570SEVENTH, LLC, a wholly owned subsidiary (the “ Borrower ”) of New York City Operating Partnership, L.P. (the “ OP ”), the operating partnership of American Strategic Investment Co. (the “ Company ”), entered into a second amendment (the “ Amendment ”) to the term loan agreement, dated April 26, 2019 (as amended, the “ Loan Agreement ”), with the Company, as guarantor of certain enumerated recourse liabilities of the Borrower under the Loan Agreement, Capital One, National Association, as administrative agent (the “ Administrative Agent ”), and the other lenders party thereto (each a “ Lender ” and together, the “ Lenders ”).”
MASS 908 Devices Inc.

908 Devices Inc. entered into Equity Purchase Agreement with CAM2 Technologies, LLC (d/b/a RedWave Technology), CAM3 HoldCo, LLC, the beneficial sellers, and Jon Frattaroli as guarantor valued at $45.0 million (effective 2024-04-29).

“On April 29, 2024, 908 Devices Inc. (the “Company”), entered into an Equity Purchase Agreement (the “Purchase Agreement”) with CAM2 Technologies, LLC, a Connecticut limited liability company (d/b/a RedWave Technology) (“RedWave”), CAM3 HoldCo, LLC, a Connecticut limited liability company (“Seller Entity”), each of the holders of outstanding equity interests of Seller Entity (the “Beneficial Sellers”, together with the Seller Entity, the “Sellers”), and Jon Frattaroli, in his capacity as a guarantor for a Beneficial Seller that is an entity pursuant to Section 10.14 of the Purchase Agreement (the “Indirect Beneficial Seller”).”
SUN Sunoco LP

Sunoco LP entered into Indenture with U.S. Bank Trust Company, National Association valued at $750 million in aggregate principal amount of its 7.000% Senior Notes due 2029 (the “2029 Notes”) an (effective 2024-04-30).

“On April 30, 2024, Sunoco LP (NYSE: SUN) (the “Partnership”) completed a private offering to eligible purchasers (the “Notes Offering”) of (i) $750 million in aggregate principal amount of its 7.000% Senior Notes due 2029 (the “2029 Notes”) and (ii) $750 million in aggregate principal amount of its 7.250% Senior Notes due 2032 (the “2032 Notes” and, collectively with the 2029 Notes, the “Notes”), along with the related guarantees of the Notes.”
MCHB Mechanics Bancorp

Mechanics Bancorp amended Amendment No. 1 with FirstSun Capital Bancorp, a Delaware corporation, and Dynamis Subsidiary, Inc., a Washington corporation and wholly owned subsidiary of FirstSun (effective 2024-04-30).

“HomeStreet, Inc., a Washington corporation (“ HomeStreet ”), entered into Amendment No. 1 (the “ Amendment ”) to the Agreement and Plan of Merger, dated January 16, 2024 (the “ Merger Agreement ”), by and among HomeStreet , FirstSun Capital Bancorp, a Delaware corporation (“ FirstSun ”), and Dynamis Subsidiary, Inc., a Washington corporation and wholly owned subsidiary of FirstSun (“ Merger Sub ”).”
CTXR Citius Pharmaceuticals, Inc.

Citius Pharmaceuticals, Inc. entered into Purchase Agreement with certain institutional investors (effective 2024-04-25).

“On April 25, 2024, Citius Pharmaceuticals, Inc. (the “Company”) entered into a securities purchase agreement (the “Purchase Agreement”) with certain institutional investors for the issuance and sale, in a registered direct offering by the Company (the “Offering”), of 21,428,574 shares of the Company’s common stock, par value $0.001 per share (the “Shares”) and warrants (the “Warrants”) to purchase up to 21,428,574 shares of common stock.”
AIR LEASE CORP

AIR LEASE CORP amended Ninth Amendment and Extension Agreement with JPMorgan Chase Bank, N.A. valued at approximately $7.8 billion (effective 2024-04-29).

“On April 29, 2024, Air Lease Corporation (the “Company”) entered into the Ninth Amendment and Extension Agreement (the “Ninth Amendment) to the Second Amended and Restated Credit Agreement which amended and extended its unsecured revolving credit facility”
DARE Dare Bioscience, Inc.

Dare Bioscience, Inc. entered into Synthetic Royalty Purchase Agreement with XOMA (US) LLC (effective 2024-04-29).

“On April 29, 2024, Daré Bioscience, Inc. (“Daré” or the “Company”) entered into a Traditional Royalty Purchase Agreement and a Synthetic Royalty Purchase Agreement (together, the “Agreements”) with XOMA (US) LLC (“XOMA”).”
DARE Dare Bioscience, Inc.

Dare Bioscience, Inc. entered into Traditional Royalty Purchase Agreement with XOMA (US) LLC valued at $22.0 million (effective 2024-04-29).

“On April 29, 2024, Daré Bioscience, Inc. (“Daré” or the “Company”) entered into a Traditional Royalty Purchase Agreement and a Synthetic Royalty Purchase Agreement (together, the “Agreements”) with XOMA (US) LLC (“XOMA”). In accordance with the Agreements, on April 29, 2024, XOMA paid $22.0 million to Daré”
BMRC Bank of Marin Bancorp

Bank of Marin Bancorp amended Amendment Number Three with Shawn Devlin and Riley Gardner (the Kelly Trust Parties) (effective 2024-04-26).

“Bank of Marin Bancorp (Nasdaq: BMRC) (the “Company”) announced that on April 26, 2024, that the Company and Shawn Devlin and Riley Gardner (Devlin and Gardner collectively, the “Kelly Trust Parties”) have amended that certain previously disclosed agreement dated May 10, 2021 (the “Agreement”), previously amended by Amendment Number One dated March 31, 2022 and Amendment Number Two dated April 25, 2023”
PRTS CarParts.com, Inc.

CarParts.com, Inc. amended Amendment No. 1 to the Tax Benefits Preservation Plan with Computershare Trust Company, N.A. (effective 2024-04-24).

“On April 24, 2024, CarParts.com, Inc. (the “Company”) entered into Amendment No. 1 to the Tax Benefits Preservation Plan (the “Amendment”).”
EBS Emergent BioSolutions Inc.

Emergent BioSolutions Inc. amended Seventh Amendment with Wells Fargo Bank, National Association valued at $270.0 million (effective 2024-04-29).

“On April 29, 2024, Emergent BioSolutions Inc. (the “Company”) entered into a Consent, Waiver and Seventh Amendment to the Amended and Restated Credit Agreement (the “Seventh Amendment”) (the “Seventh Amendment”), among the Company, as borrower, Wells Fargo Bank, National Association, as administrative agent (in such capacity, the “Administrative Agent”) and certain lenders party thereto.”
LEXX Lexaria Bioscience Corp.

Lexaria Bioscience Corp. entered into Warrant Exercise Agreement with an existing accredited investor valued at approximately $4.7 million (effective 2024-04-30).

“On April 30, 2024, Lexaria Bioscience Corp. (the “Company”) entered into a warrant exercise agreement (the “Warrant Exercise Agreement”) with an existing accredited investor (the “Investor”) to exercise in full an outstanding Common Stock Purchase Warrant (the “Exercise”) to purchase up to an aggregate of 2,917,032 shares of the Company’s common stock (the “Existing Warrant”).”
XXII 22nd Century Group, Inc.

22nd Century Group, Inc. entered into General Release and Settlement Agreement with Omnia Capital LP valued at approximately $5.2 million (effective 2024-04-29).

“On April 29, 2024, 22nd Century Group, Inc. (the “Company”) entered into a General Release and Settlement Agreement (the “Agreement”) with Omnia Capital LP (“Omnia”).”

Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.